Import Medicaments (excluding Goods of Heading 3002, 3005 or 3006) Consisting of Two or More Constituents Which Have Been Mixed Together for Therapeutic or Prophylactic Uses, not Put Up in Measured Doses or in Forms or Packings for Retail Sale from South Korea

Import trade data for Indian businesses

🇰🇷 South Korea — Country Profile

Capital

Seoul

GDP (USD)

$2K

Population

51.7M

Currency

Won

Trade Agreement

APTA, India-Korea CEPA

Import Snapshot

India imported $927K of medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale from South Korea in 2024 -84.9% YoY.

Based on HS Code 3003 import data (UN Comtrade)

Import History — South Korea to India

2024

$927K

HS 3003 imports

2023

$6.1M

HS 3003 imports

2022

$4.5M

HS 3003 imports

About Medicaments (excluding Goods of Heading 3002, 3005 or 3006) Consisting of Two or More Constituents Which Have Been Mixed Together for Therapeutic or Prophylactic Uses, not Put Up in Measured Doses or in Forms or Packings for Retail Sale Imports from South Korea

South Korea is one of the supplying countries for medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale to the Indian market, classified under HS heading 3003. Indian importers source this product for domestic consumption, manufacturing inputs, or re-export.

Other Countries Supplying Medicaments (excluding Goods of Heading 3002, 3005 or 3006) Consisting of Two or More Constituents Which Have Been Mixed Together for Therapeutic or Prophylactic Uses, not Put Up in Measured Doses or in Forms or Packings for Retail Sale to India

Import Medicaments (excluding Goods of Heading 3002, 3005 or 3006) Consisting of Two or More Constituents Which Have Been Mixed Together for Therapeutic or Prophylactic Uses, not Put Up in Measured Doses or in Forms or Packings for Retail Sale from South Korea

Get expert guidance on sourcing, customs procedures, and compliance.

Contact XIMPEX